8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
West Pharmaceutical ($WST) filed Form 8‑K (Item 9.01) to furnish a press release dated Mar 9, 2026…
Filed with the SEC on · Summarized by InvestorsBot
West Pharmaceutical ($WST) filed Form 8‑K (Item 9.01) to furnish a press release dated Mar 9, 2026 (Exhibit 99.1). No financial statements included; cover page provided in Inline XBRL (Exhibit 104). 📄 #8K #SECfiling
Press release is "furnished, not filed," which limits new liability under the Securities Exchange Act. Investors should review Exhibit 99.1 for substance and any material updates. $WST 🗞️ #pharma #investing
8‑K signed Mar 9, 2026 by Norman D. Finch Jr., SVP, General Counsel & Corporate Secretary. Monitor the company press release for any operational or guidance changes. $WST ✍️ #corporategovernance